LC
SRNE

Lindbrook Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Lindbrook Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-941
Closed -$1K – 3085
2022
Q3 		$1K Sell
941
-115
-11% -$261 ﹤0.01% 2583
2022
Q2 		$2K Buy
+1,056
New +$1.83K ﹤0.01% 2109
2022
Q1 		– Sell
-8,481
Closed -$39K – 2668
2021
Q4 		$39K Buy
8,481
+8,134
+2,344% +$50.5K 0.01% 805
2021
Q3 		$3K Hold
347
– – ﹤0.01% 1474
2021
Q2 		$3K Hold
347
– – ﹤0.01% 1532
2021
Q1 		$3K Sell
347
-96
-22% -$1.01K ﹤0.01% 1488
2020
Q4 		$3K Buy
443
+14
+3% +$112 ﹤0.01% 1396
2020
Q3 		$5K Sell
429
-62
-13% -$567 ﹤0.01% 1141
2020
Q2 		$3K Buy
491
+144
+41% +$551 ﹤0.01% 1324
2020
Q1 		$1K Buy
+347
New +$999 ﹤0.01% 1625

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM